DGAP-Adhoc: TAG Immobilien AG: Tender offer to shareholders

New Post Public Reply Private Reply Replies (0) Message Board

News Desk 2018

Sep 11, 2014 at 11:45 AM

DGAP-Adhoc: TAG Immobilien AG: Tender offer to shareholders to purchase up to 13,129,831 shares - Rolf Elgeti, CEO of TAG, plans to move from the Company's Management Board to the Supervisory Board

TAG Immobilien AG / Key word(s): Share Buyback 11.09.2014 17:26 Dissemination of an Ad hoc announcement according to Â§ 15 WpHG, transmitted by DGAP - a service of EQS Group AG. The issuer is solely responsible for the content of this announcement. --------------------------------------------------------------------------- TAG IMMOBILIEN AG: AD-HOC DISCLOSURE PURSUANT TO Â§ 15 WPHG TAG Immobilien AG: - Tender offer to shareholders to purchase up to 13,129,831 shares - Rolf Elgeti, CEO of TAG, plans to move from the Company's Management Board to the Supervisory Board Hamburg, September 11, 2014 - TAG Immobilien AG (the "Company") has today resolved on a tender offer to purchase for cash for up to 13,129,831 of its shares. The buy-back offer will be made in the form of a modified Dutch auction tender offer with an offer price range between EUR 8.35 and EUR 9.35 per share. The closing price of the Company's shares on September 10, 2014 on the regulated market (Prime Standard) of the Frankfurt Stock Exchange was EUR 8.77. The shareholders of the Company may accept the offer by tendering all or part of their shares at a price within the offer price range. The final offer price, which will be the same for all shares, will be calculated on the basis of the total number of tendered shares and the tender prices of the shareholders. It will correspond to the lowest price that allows the Company to purchase 13,129,831 shares. The acceptance period for the tender offer is currently scheduled to start on September 15, 2014 and to end at midnight (CEST) on October 14, 2014. The tender offer is subject to certain terms and conditions that are described in the Offer Document expected to be published on September 15, 2014 (on the first day of the acceptance period). The tender offer will be available on the Company's web site at www.tag-ag.com under the section "Investor Relations" in the sub-section "Share Buy-Back Offer" and on the same date in the Federal Gazette (Bundesanzeiger). Shareholders are urged to read the tender offer document as it contains important information that shareholders should consider before making any decision to tender their shares. Following a period of high growth and successful integration of acquisitions Rolf Elgeti, CEO of TAG, regards his mission as completed and has therefore today requested to be released early from his duty as CEO with effect from 31 October 2014. The Supervisory board has accepted his request. Mr. Elgeti is willing to move to the Company's Supervisory Board at the next possible opportunity. To be able to continue to rely on Mr. Elgeti's strategic expertise for the benefit of TAG, the Supervisory Board supports his move to the Supervisory Board and subsequent appointment as chairman of the supervisory body, provided a sufficient backing of shareholders is given. Note: This announcement is for informational purposes only and does not constitute an offer to purchase, or a solicitation of an offer to sell or exchange, any securities of the Company, nor will there be any offer to purchase, solicitation of an offer to sell, or any purchase of securities of the Company in any jurisdiction in which such offer, solicitation or purchase would be unlawful. The solicitation of offers is made solely by the Offer Document referred to above. End of ad-hoc release. Contact: TAG Immobilien AG Head of Investor and Public Relations Dominique Mann Tel. +49 (0) 40 380 32 - 300 Fax +49 (0) 40 380 32 390 ir@tag-ag.com 11.09.2014 The DGAP Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases. Media archive at www.dgap-medientreff.de and www.dgap.de --------------------------------------------------------------------------- Language: English Company: TAG Immobilien AG SteckelhÃ¶rn 5 20457 Hamburg Germany Phone: 040 380 32 0 Fax: 040 380 32 390 E-mail: ir@tag-ag.com Internet: http://www.tag-ag.com ISIN: DE0008303504, XS0954227210, DE000A12T101 WKN: 830350, A1TNFU, A12T10 Indices: MDAX Listed: Regulierter Markt in Frankfurt (Prime Standard), MÃ¼nchen; Freiverkehr in Berlin, DÃ¼sseldorf, Hamburg, Hannover, Stuttgart End of Announcement DGAP News-Service ---------------------------------------------------------------------------

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

BETR's Slide: Investors Face Big Losses, Leadership Shift

BETR Investors Left in the Lurch It's a real trainwreck, folks. Better Home & Finance Holding Company, trading under NASDAQ:BETR, is in the spotlight for all the wrong reasons. The company expanded the class period for its investor lawsuit to include even more dates between March and August 2026, reflecting a torturous ride for shareholders. Their stock cratered by a...

Novo's Research Unlocks New Insights into Food Noise

Unpacking the Science Behind Food Noise When folks think about losing weight, most picture shedding pounds and fitting into those elusive smaller jeans. But get this—there’s a curveball called ‘food noise’ that’s making waves in obesity treatment. Novo Nordisk’s semaglutide injections are shaking things up, cutting down on those persistent thoughts about food....

WeaveGrid Powers EVConnectNC: Charging Incentives Launched

Transforming Utilities with EVConnectNC In a fresh move by WeaveGrid, North Carolina's Electric Cooperatives have teamed up to roll out EVConnectNC. This innovative program aims to manage the burgeoning demand for electric vehicle (EV) charging in rural and suburban areas under North Carolina's cooperative umbrella. Think of it as a smart way to handle new loads without...

Lilly's Obesity Breakthroughs: A Step Beyond the Scale

Pushing the Boundaries of Obesity Treatment Alright, let's cut through the noise and get to what really matters here. Eli Lilly is taking on obesity treatment like it's Clash of the Titans at this year's ObesityWeek 2026 in Washington, D.C. Forget just dropping pounds—Lilly wants to reshape how we think about obesity entirely. They're not just leaning into the scale,...

Webull Faces Class Action: Key Details for Investors

What's Really Going on With Webull? When you hear there's a class-action lawsuit brewing, you know something's gone real sideways. Webull Corporation (NASDAQ: BULL) finds itself neck-deep in a securities fraud class action alleging some dicey dealings with China. If you've got skin in the game—and if you bought Webull stock between April 26, 2025, and October 6,...

Servier's Data on Tovorafenib Shows Promise in pLGG

New Light on a Critical Challenge Talk about a fight in the dark. Pediatric low-grade glioma (pLGG) is a menace that families dread, an uphill battle with odds that feel relentless. Enter Servier and its four-year updated data on OJEMDA® (tovorafenib), a beacon of hope for kids battling these tricky brain tumors. Results, presented at the SNO meeting, are fresh off the...

El Pollo Loco Faces Class Action Over Wage Practices

Alright, here's where things start sizzling—El Pollo Loco, the fast-food chicken chain whose name translates to 'The Crazy Chicken'—is in a legal pickle. The lawsuit hanging over their heads could spell a sticky situation for them and possibly ripple through the fast-food industry. The suit, filed by the steadfast firm Blumenthal Nordrehaug Bhowmik De Blouw LLP, has...

HONGQI's EHS4 Launch in Europe: Bridging East and West

Revving Up a New Chapter: HONGQI in Venice There's a new player in the European automotive scene, and it's rolling in with more style than a Venetian gondola. HONGQI, a name that's been turning gears in China since '58, is packing its suitcases full of Eastern elegance and landing straight in Venice with the all-electric EHS4. On November 16, the brand is set to unveil...

Novo's CagriSema Trial Shows Promising Obesity Results

Novo's Latest Weight Loss Gamble Well, look what we have here. Novo Nordisk is shaking up the obesity treatment scene with some bold numbers from their REDEFINE 9 trial. The investigational CagriSema combo of amylin analog and GLP-1 receptor agonist has churned out an eyeball-popping near 21% weight loss. For context, we're staring down the barrel of numbers far meatier...

Advanta's Game-Changer: Acquiring Misr Hytech to Expand in Africa

Advanta's Strategic Move into Africa Alright, let's cut to the chase. Advanta is making a big splash with its acquisition of Misr Hytech, a move that's going to shake things up in Africa's agricultural sector. This isn't just another merger to gloss over with your morning coffee. We're talking about a deal that's supposed to wrap up by January 31, 2027, bringing together...